Burning Rock Biotech Ltd Net Income Loss

• Burning Rock Biotech Ltd showed an increase of +47.0% in Net Income Loss from 2023 to 2024.
• This data is from Burning Rock Biotech Ltd's annual report (Form 10-K), filed with the SEC on April 29, 2025.
• XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2018 to 2024), Burning Rock Biotech Ltd's Net Income Loss has declined by 95.3%.
• Historical annual values: Fiscal year 2024: -$346.63 million | Fiscal year 2023: -$653.69 million | Fiscal year 2022: -$971.23 million | Fiscal year 2021: -$796.70 million | Fiscal year 2020: -$407.24 million | Fiscal year 2019: -$169.16 million | Fiscal year 2018: -$177.50 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026